A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

Ruben A. Mesa, David P. Steensma, Animesh Pardanani, Chin Yang Li, Michelle Elliott, Scott H. Kaufmann, Gregory Wiseman, Leigh A. Gray, Georgene Schroeder, Terra Reeder, Jerome B. Zeldis, Ayalew Tefferi

Research output: Contribution to journalArticlepeer-review

242 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds